Toronto Dominion Bank’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-9
Closed -$2.58K – 2575
2026
Q2
$2.58K Buy
+9
New +$1.72K ﹤0.01% 2161
2026
Q1
– Sell
-7
Closed -$1.11K – 2274
2025
Q4
$1.11K Buy
+7
New +$961 ﹤0.01% 1930

Other funds holding LABU

Toronto Dominion Bank's LABU Position: Q3 2026 in Review

Toronto Dominion Bank sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q3 2026, closing a stake of 9 shares — an estimated $2.58K sold.

Toronto Dominion Bank first reported a position in LABU in Q4 2025 and held it in 2 quarters. The position peaked at $2.58K in Q2 2026. 38 funds tracked by Wall St. Rank hold LABU as of Q3 2026.

  • Toronto Dominion Bank reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q3 2026 after selling out during the quarter.
  • Toronto Dominion Bank sold 9 Direxion Daily S&P Biotech Bull 3X ETF shares in Q3 2026, an estimated $2.58K.
  • Toronto Dominion Bank first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2025 and held it in 2 quarters.
  • Toronto Dominion Bank's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $2.58K in Q2 2026.
  • 38 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q3 2026.

Based on Toronto Dominion Bank's 13F filing for Q3 2026, filed 16 Nov 2026.